PMID- 15207361 OWN - NLM STAT- MEDLINE DCOM- 20040824 LR - 20161124 IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 126 IP - 2 DP - 2004 TI - Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. PG - 433-40 AB - Vitamin E has been shown to have protective effects against cerebral ischemia, possibly due to its anti-oxidant effects. However, its non-anti-oxidant, intracellular molecular mechanism remains elusive. For in vivo experiments in rats, orally administered vitamin E significantly reduced not only the brain infarct volume but also space navigation disability after permanent middle cerebral artery (MCA) occlusion. The level of anti-oxidant after MCA occlusion was significantly increased specifically in the ipsilateral brain tissues of vitamin E-treated rats. For in vitro experiments, posttreatment with vitamin E protected primary cultured neurons from nitric oxide-induced insult. Vitamin E induced the expression of the alpha subunit of hypoxia-inducible factor-1 (HIF-1) and its target genes, including vascular endothelial growth factor (VEGF) and heme oxygenase-1. The hypoxia response element on the VEGF promoter was responsible for this vitamin E-induced transcriptional activation of VEGF gene. Taken together, these results suggest that cerebral infarction increased the permeability of vitamin E across the blood-brain barrier, and this increased vitamin E in brain tissue elicited neuroprotective effects not only through scavenging oxidants, as are previously well reported, but also by transactivating HIF-1-dependent genes, which results in protection of brains from ischemic insults. CI - Copyright 2004 IBRO FAU - Zhang, B AU - Zhang B AD - Department of Physiology, School of Medicine, Ehime University, Shitsukawa, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan. FAU - Tanaka, J AU - Tanaka J FAU - Yang, L AU - Yang L FAU - Yang, L AU - Yang L FAU - Sakanaka, M AU - Sakanaka M FAU - Hata, R AU - Hata R FAU - Maeda, N AU - Maeda N FAU - Mitsuda, N AU - Mitsuda N LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0 (Antioxidants) RN - 0 (DNA-Binding Proteins) RN - 0 (Heat-Shock Proteins) RN - 0 (Hif1a protein, rat) RN - 0 (Hypoxia-Inducible Factor 1) RN - 0 (Hypoxia-Inducible Factor 1, alpha Subunit) RN - 0 (Neuroprotective Agents) RN - 0 (Nuclear Proteins) RN - 0 (Transcription Factors) RN - 0 (Vascular Endothelial Growth Factor A) RN - 0 (vascular endothelial growth factor A, rat) RN - 1406-18-4 (Vitamin E) RN - EC 1.13.- (Oxygenases) RN - EC 1.14.14.18 (Heme Oxygenase (Decyclizing)) RN - EC 1.14.14.18 (Hmox1 protein, rat) SB - IM MH - Animals MH - Antioxidants/metabolism MH - Brain Ischemia/genetics/metabolism/*prevention & control MH - Cell Death/drug effects/physiology MH - DNA-Binding Proteins/*biosynthesis/genetics MH - Dose-Response Relationship, Drug MH - Escape Reaction/drug effects/physiology MH - Heat-Shock Proteins/*biosynthesis/genetics MH - Heme Oxygenase (Decyclizing) MH - Hypoxia-Inducible Factor 1 MH - Hypoxia-Inducible Factor 1, alpha Subunit MH - Male MH - Neurons/drug effects/metabolism MH - Neuroprotective Agents/pharmacology/therapeutic use MH - Nuclear Proteins/*biosynthesis/genetics MH - *Oxygenases MH - Rats MH - Rats, Inbred SHR MH - *Transcription Factors MH - Vascular Endothelial Growth Factor A/*biosynthesis/genetics MH - Vitamin E/pharmacology/*therapeutic use EDAT- 2004/06/23 05:00 MHDA- 2004/08/25 05:00 CRDT- 2004/06/23 05:00 PHST- 2004/03/22 00:00 [accepted] PHST- 2004/06/23 05:00 [pubmed] PHST- 2004/08/25 05:00 [medline] PHST- 2004/06/23 05:00 [entrez] AID - S0306452204002246 [pii] AID - 10.1016/j.neuroscience.2004.03.057 [doi] PST - ppublish SO - Neuroscience. 2004;126(2):433-40. doi: 10.1016/j.neuroscience.2004.03.057.